Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal Post author:Sam Post published:December 26, 2017 Post category:BioPharma Mallinckrodt picks up Sucampo’s Amitiza as well as two other pipeline compounds. Source: BioSpace You Might Also Like Questions Remain Over Suicide Death of Genentech Lobbyist February 14, 2017 GlaxoSmithKline is Eyeing Pfizer's $15B+ Consumer Biz January 9, 2018 It's Official: Shire Takes Over Ariad's Old Space in Kendall Square October 8, 2017
